Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK

被引:5
|
作者
Simons, Rob W. P. [1 ]
Dickman, Mor M. [1 ]
van den Biggelaar, Frank J. H. M. [1 ]
Dirksen, Carmen D. [2 ]
Van Rooij, Jeroen [3 ]
Remeijer, Lies [3 ]
Van der Lelij, Allegonda [4 ,5 ]
Wijdh, Robert H. J. [6 ]
Kruit, Pieter J. [7 ]
Nuijts, Rudy M. M. A. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Univ Eye Clin Maastricht, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands
[3] Rotterdam Eye Hosp, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[5] Cent Mil Hosp, Dept Ophthalmol, Utrecht, Netherlands
[6] Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands
[7] Euro Tissue Bank, Beverwijk, Netherlands
关键词
corneal transplantation; cost-effectiveness; costs; Descemet stripping automated endothelial keratoplasty; Fuchs' endothelial dystrophy; quality-adjusted life years; ultrathin Descemet stripping automated endothelial keratoplasty; POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; OUTCOMES;
D O I
10.1111/aos.14126
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the cost-effectiveness of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus standard DSAEK. Methods A cost-effectiveness analysis using data from a multicentre randomized clinical trial was performed. The time horizon was 12 months postoperatively. Sixty-four eyes of 64 patients with Fuchs' endothelial dystrophy were included and randomized to UT-DSAEK (n = 33) or DSAEK (n = 31). Relevant resources from healthcare and societal perspectives were included in the cost analysis. Quality-adjusted life years (QALYs) were determined using the Health Utilities Index Mark 3 questionnaire. The main outcome was the incremental cost-effectiveness ratio (ICER; incremental societal costs per QALY). Results Societal costs were euro9431 (US$11 586) for UT-DSAEK and euro9110 (US$11 192) for DSAEK. Quality-adjusted life years (QALYs) were 0.74 in both groups. The ICER indicated inferiority of UT-DSAEK. The cost-effectiveness probability ranged from 37% to 42%, assuming the maximum acceptable ICER ranged from euro2500-euro80 000 (US$3071-US$98 280) per QALY. Additional analyses were performed omitting one UT-DSAEK patient who required a regraft [ICER euro9057 (US$11 127) per QALY, cost-effectiveness probability: 44-62%] and correcting QALYs for an imbalance in baseline utilities [ICER euro23 827 (US$29 271) per QALY, cost-effectiveness probability: 36-59%]. Furthermore, the ICER was euro2101 (US$2581) per patient with clinical improvement in best spectacle-corrected visual acuity (>= 0.2 logMAR) and euro3274 (US$4022) per patient with clinical improvement in National Eye Institute Visual Functioning Questionnaire-25 composite score (>= 10 points). Conclusion The base case analysis favoured DSAEK, since costs of UT-DSAEK were higher while QALYs were comparable. However, additional analyses revealed no preference for UT-DSAEK or DSAEK. Further cost-effectiveness studies are required to reduce uncertainty.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 50 条
  • [1] Trial-based cost-effectiveness analysis of Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) versus DSAEK
    Simons, R. W. P.
    Dickman, M. M.
    van den Biggelaar, F. J. H. M.
    Dirksen, C. D.
    Van der Lelij, A.
    van Rooij, J.
    Remeijer, L.
    Wijdh, R. H. J.
    Nuijts, R. M. M. A.
    ACTA OPHTHALMOLOGICA, 2017, 95 : 6 - 6
  • [2] Trial-based cost-effectiveness analysis of Descemet Membrane Endothelial Keratoplasty (DMEK) versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK)
    Simons, R. W. P.
    Dunker, S. L.
    Dickman, M. M.
    van den Biggelaar, F. J. H. M.
    Dirksen, C. D.
    Nuijts, R. M. M. A.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 7 - 8
  • [3] Trial-based cost-effectiveness analysis of Descemet membrane endothelial keratoplasty (DMEK) versus ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK)
    Simons, Rob W. P.
    Dunker, Suryan L.
    Dickman, Mor M.
    Nuijts, Rudy M. M. A.
    van den Biggelaar, Frank J. H. M.
    Dirksen, Carmen D.
    ACTA OPHTHALMOLOGICA, 2023, 101 (03) : 319 - 329
  • [4] Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK)-a systematic review and meta-analysis
    Hurley, Daire J.
    Murtagh, Patrick
    Guerin, Marc
    EYE, 2023, 37 (14) : 3026 - 3032
  • [5] Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK)—a systematic review and meta-analysis
    Daire J. Hurley
    Patrick Murtagh
    Marc Guerin
    Eye, 2023, 37 : 3026 - 3032
  • [6] Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) vs Ultra-Thin DSAEK (UT-DSAEK) vs Descemet's Membrane Endothelial Keratoplasty (DMEK)
    Yan, Peng
    Teja, Salina
    Baig, Kashif
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [7] Interim analysis of a randomized controlled trial comparing ultrathin descemet stripping automated endothelial keratoplasty (UT-DSAEK) vs descemet membrane endothelial keratoplasty (DMEK)
    Dunker, S. L.
    Dickman, M. M.
    Wisse, R. P. L.
    Nobacht, S.
    Wijdh, R. H. J.
    Bartels, M. C.
    Tang, N. E. M. L.
    van den Biggelaar, F. J. H. M.
    Berendschot, T. T. J. M.
    Nuijts, R. M. M. A.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 8 - 8
  • [8] A Randomized Multicenter Clinical Trial of Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) versus DSAEK
    Dickman, Mor M.
    Kruit, Pieter J.
    Remeijer, Lies
    van Rooij, Jeroen
    Van der Lelij, Allegonda
    Wijdh, Robert H. J.
    van den Biggelaar, Frank J. H. M.
    Berendschot, Tos T. J. M.
    Nuijts, Rudy M. M. A.
    OPHTHALMOLOGY, 2016, 123 (11) : 2276 - 2284
  • [9] Preliminary results of a multicenter randomized clinical trial comparing Descemet Membrane Endothelial Keratoplasty (DMEK) with ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK)
    Dickman, Mor M.
    Dunker, Suryan
    Wisse, Robert
    Wijdh, Robert J.
    Nobacht, Siamak
    Bartels, Marjolijn C.
    Tang, Mei L.
    van den Biggelaar, Frank J. H. M.
    Berendschot, Tos T. J. M.
    Nuijts, Rudy M. M. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] Outcomes of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) performed in eyes with failure of primary Descemet membrane endothelial keratoplasty (DMEK)
    Graffi, Shmuel
    Leon, Pia
    Nahum, Yoav
    Gutfreund, Shay
    Spena, Rossella
    Mattioli, Leila
    Busin, Massimo
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (05) : 599 - 603